We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+7.93%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$95.8M
(+8.9%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
316
New
41
Increased
130
Reduced
90
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MiMedx Group
MDXG
|
+$10.3M |
| 2 |
OneMain Financial
OMF
|
+$8.99M |
| 3 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$8.85M |
| 4 |
Protolabs
PRLB
|
+$8.64M |
| 5 |
MTOR
MERITOR, Inc.
MTOR
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MasTec
MTZ
|
+$14.6M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.16M |
| 3 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$7.88M |
| 4 |
Papa John's
PZZA
|
+$7.27M |
| 5 |
AHL
ASPEN Insurance Holding Limited
AHL
|
+$7.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.52% |
| 2 | Industrials | 14.47% |
| 3 | Technology | 13.37% |
| 4 | Consumer Discretionary | 12.24% |
| 5 | Healthcare | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Amphastar Pharmaceuticals
AMPH
$846M
| $937K | 0.08% |
52,417
| – | – |
|
202
NeoGenomics
NEO
$1.71B
| $893K | 0.08% |
80,233
| – | – |
|
203
Cullen/Frost Bankers
CFR
$10.3B
| $893K | 0.08% |
9,406
-5,244
| -36% | -$474K |
|
204
Future Fuel
FF
$203M
| $880K | 0.07% |
+55,905
| New | +$807K |
|
205
Synaptics
SYNA
$4.55B
| $874K | 0.07% |
22,298
+10,444
| +88% | +$471K |
|
|
CWBC
206
Community West Bancshares
CWBC
$686M
| $863K | 0.07% |
38,679
+26,416
| +215% | +$550K |
|
207
Myers Industries
MYE
$1.23B
| $848K | 0.07% |
+40,459
| New | +$743K |
|
208
Reliance Steel & Aluminium
RS
$20.6B
| $830K | 0.07% |
10,892
-10,193
| -48% | -$745K |
|
209
Nelnet
NNI
$4.81B
| $809K | 0.07% |
16,020
| – | – |
|
210
PC Connection
CNXN
$2.05B
| $794K | 0.07% |
28,166
+8,691
| +45% | +$226K |
|
|
EVRI
211
DELISTED
Everi Holdings
EVRI
| $791K | 0.07% |
104,217
+73,913
| +244% | +$556K |
|
212
Jabil
JBL
$32.6B
| $760K | 0.06% |
+26,624
| New | +$805K |
|
|
EXAC
213
DELISTED
Exactech Inc
EXAC
| $754K | 0.06% |
22,874
+1,756
| +8% | +$52.8K |
|
|
CMD
214
DELISTED
Cantel Medical Corporation
CMD
| $742K | 0.06% |
7,877
+469
| +6% | +$37K |
|
215
NETSCOUT
NTCT
$2.91B
| $728K | 0.06% |
22,490
| – | – |
|
216
Primerica
PRI
$9.81B
| $716K | 0.06% |
+8,775
| New | +$685K |
|
|
ALTA
217
DELISTED
Altabancorp
ALTA
| $690K | 0.06% |
21,266
+13,346
| +169% | +$372K |
|
|
MGLN
218
DELISTED
Magellan Health Services, Inc.
MGLN
| $689K | 0.06% |
7,982
-542
| -6% | -$42.7K |
|
|
XENT
219
DELISTED
Intersect ENT, Inc
XENT
| $687K | 0.06% |
22,055
+1,119
| +5% | +$33.1K |
|
220
Core Molding Technologies
CMT
$208M
| $682K | 0.06% |
+31,068
| New | +$652K |
|
221
Vanda Pharmaceuticals
VNDA
$314M
| $682K | 0.06% |
38,075
| – | – |
|
|
BPFH
222
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $679K | 0.06% |
41,011
-153
| -0.4% | -$2.31K |
|
|
AMAG
223
DELISTED
AMAG Pharmaceuticals
AMAG
| $666K | 0.06% |
36,108
-339
| -0.9% | -$6.32K |
|
224
Lear
LEA
$7.26B
| $652K | 0.06% |
3,766
| – | – |
|
225
Hallador Energy
HNRG
$717M
| $642K | 0.05% |
112,197
+1,521
| +1% | +$9.87K |
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Matarin Capital Management held 316 positions worth $1.18B, up 8.9% from $1.08B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $38.3M of net new capital in Q3 2017, opening 41 new positions and adding to 130 existing holdings. Its largest new stake was MiMedx Group: 694,135 shares worth $8.25M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Papa John's, an estimated $7.27M trimmed.
- Matarin Capital Management's largest Q3 2017 buy was MiMedx Group: 694,135 shares worth $8.25M.
- Matarin Capital Management added most to Protolabs in Q3 2017, an estimated $8.64M increase.
- Matarin Capital Management's biggest Q3 2017 reduction was Papa John's, cutting an estimated $7.27M.
- Matarin Capital Management fully exited MasTec in Q3 2017, selling an estimated $14.6M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.18B portfolio in Q3 2017.
- Matarin Capital Management opened 41 new positions and closed 25 in Q3 2017.
- Matarin Capital Management's portfolio value rose 8.9% quarter-over-quarter to $1.18B.
Based on Matarin Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.